Does Covishield Cause Blood Clot?
July 24, 2023 | by Yashaswi Pathakamuri | Posted in FAQ's
There have been rare reports of blood clotting disorders associated with the Oxford-AstraZeneca COVID-19 vaccine, known as Covishield in some countries. The specific condition linked to the vaccine is called “vaccine-induced immune thrombotic thrombocytopenia” (VITT). This condition involves blood clotting combined with a low platelet count.
It is essential to emphasize that VITT is an extremely rare side effect, and the overall risk of developing blood clots after receiving the Covishield vaccine or any other COVID-19 vaccine is very low. The benefits of COVID-19 vaccination in preventing severe illness, hospitalization, and death from the virus far outweigh the risks of potential side effects.
Health authorities and regulatory agencies around the world, such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), have continued to recommend the use of COVID-19 vaccines like Covishield based on their safety and effectiveness profiles.
As new information and research may have emerged after my last update, I recommend checking the latest guidance from reputable health organizations or consulting with healthcare professionals for the most current information on COVID-19 vaccines and potential side effects.